Morphic Holding, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACLX
|
Arcellx, Inc. | $82.74 | $2.72 B | -49.3 | 130 | $110.32 M |
 AKRO
|
Akero Therapeutics, Inc. | $28.25 | $1.59 B | -7.1 | 61 | $0 |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 ETNB
|
89bio, Inc. | $7.26 | $796.91 M | -4.05 | 70 | $0 |
 IMCR
|
Immunocore Holdings plc | $31.39 | $2.08 B | -26.72 | 497 | $249.43 M |
 INZY
|
Inozyme Pharma, Inc. | $5.18 | $286.39 M | -3.43 | 59 | $0 |
 MDGL
|
Madrigal Pharmaceuticals, Inc. | $212.44 | $5.21 B | -10.55 | 376 | $0 |
 PCVX
|
Vaxcyte, Inc. | $113.14 | $7.72 B | -16.54 | 254 | $0 |
 PLRX
|
Pliant Therapeutics, Inc. | $11.32 | $672.63 M | -3.9 | 166 | $1.58 M |
 PTGX
|
Protagonist Therapeutics, Inc. | $44.54 | $2.04 B | 13.7 | 125 | $60.00 M |
 RNA
|
Avidity Biosciences, Inc. | $42.32 | $2.54 B | -8.99 | 253 | $9.56 M |
 RVMD
|
Revolution Medicines, Inc. | $44.15 | $6.66 B | -10.51 | 443 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $12.23 | $774.50 M | -6.14 | 110 | $8.78 M |
 TERN
|
Terns Pharmaceuticals, Inc. | $8.52 | $462.44 M | -5.67 | 66 | $0 |
 VKTX
|
Viking Therapeutics, Inc. | $61.68 | $6.17 B | -60.86 | 28 | $0 |
 VTYX
|
Ventyx Biosciences, Inc. | $2.31 | $229.83 M | -1.01 | 73 | $0 |